What if a tiny change in our DNA could alter a protein enough to influence disease susceptibility?
A recent in-silico study explored this question in ankylosing spondylitis (AS) by investigating two biologically important genes — VDR and BMP2.
VDR regulates vitamin-D-mediated calcium homeostasis, bone metabolism and immune responses.
BMP2 is a key regulator of osteoblast differentiation and bone formation — processes highly relevant to the abnormal ossification observed in AS.
The researchers computationally screened hundreds of missense variants using an integrated bioinformatics workflow involving SIFT, PolyPhen-2, PROVEAN, Mutation Assessor, Meta-SNP, SNAP-2, SNPs&GO, PANTHER and PhD-SNP.
But identifying a mutation is only the beginning.
We then used I-Mutant and MUpro to analyze the protein stability, which indicated that the predicted variants may decrease protein stability. ConSurf also revealed that many variants are in evolutionarily conserved regions, which may be more functionally significant.
Project HOPE revealed changes in amino acid size, charge, and hydrophobicity caused by several substitutions—molecular alterations that could influence protein structure and function.
Meanwhile, GeneMANIA and STRING placed VDR and BMP2 within broader gene/protein interaction networks, highlighting how individual variants could potentially influence interconnected pathways involved in immune regulation and bone remodeling.
Instead of experimentally testing thousands of genetic variants one by one, computational biology can help narrow the search to variants most likely to have functional consequences.
A combination of genomics, structural bioinformatics, network biology, molecular dynamics, and experimental validation can give a much deeper insight into the contribution of genetic variation to AS.
The future of precision medicine may not begin with treating the disease—it may begin with understanding the variant.
Share your valuable thoughts on future research directions and possibilities for this!
MBH/PS
